Benefits of a combined surgical technique for patients with secondary neovascular glaucoma

Author:

Rykov Sergiy O.1,Shargorodska Iryna V.1,Novak Liudmyla P.1,Lіchman Lada Yu.2,Luhovskyi Oleksandr F.3,Sharhorodskyi Serhii V.3,Sas Olha S.1

Affiliation:

1. BOGOMOLETS NATIONAL MEDICAL UNIVERSITY, KYIV, UKRAINE

2. SHUPYK NATIONAL HEALTHCARE UNIVERSITY OF UKRAINE, KYIV, UKRAINE

3. NATIONAL TECHNICAL UNIVERSITY OF UKRAINE ≪IGOR SIKORSKY KYIV POLYTECHNIC INSTITUTE≫, KYIV, UKRAINE

Abstract

Aim: To assess the effectiveness and safety of the proposed surgical technique for treating secondary neovascular glaucoma. Materials and Methods: We examined 28 eyes of 28 patients (16 women and 12 men), aged 46}7,2 years, with secondary neovascular glaucoma. All patients underwent a comprehensive ophthalmological examination before and during treatment. Two-stage treatment was applied to all patients. At the first stage – performed an advanced technique of non-penetrating deep sclerectomy while administering anti-VEGF (anti-vascular endothelial growth factor) intravitreal or intracameral injections. At the second – we performed externalization of Schlemm’s canal followed by YAG laser trabeculectomy. Statistical analysis of the results was used the SPSS v. 11.0, MedStat v.15.1 software package for medical and biological research. Results: The proposed surgical technique, leads to a gradual decrease in intraocular pressure (IOP) and regression of the iris and anterior chamber angle neovascularization. The postoperative course was uneventful for all the patients. In the early postoperative period, the IOP was observed to be normalized in all the eyes. The IOP ranged from 12 to 16 mm Hg. The neovascularization regression occurred (in 100 % of cases) within 5-7 days. Conclusions: Gradual reduction of IOP reduces intraoperative complications. Intravitreal or intracameral injections of anti-proliferative agents contribute to the regression of neovascularization and further gradual reduction of IOP. Performing a laser trabeculectomy in the area where a non-penetrating deep sclerectomy was previously performed creates new pathways for the outflow of intraocular fluid from the anterior chamber and reduces the risks of reintervention.

Publisher

ALUNA

Reference15 articles.

1. 1. Mogilevskiy SYu, Korobova AV, Hadri W. Svyaz’ provospalitel’nykh tsitokinov vnutriglaznoy zhidkosti s razvitiyem posleoperatsionnykh oslozhneniy u bol’nykh pervichnoy glaukomoy v sochetanii s kataraktoy [Association of pro-inflammatory cytokines in the intraocular fluid with the development of postoperative complications in patients with primary glaucoma in combination with cataracts]. Archive of Ukrainian Ophthalmology. 2017;2(8):38–44. doi: 10.22141/2309-8147.5.2.2017.172452. (Ukrainian)

2. 2. Pavlyuchenko KP, Mogilevskiy SYu, Zyablitsev SV et al. Dinamika razvitiya neovaskulyarizatsii raduzhki v zavisimosti ot urovnya vazomotornykh faktorov u bol’nykh neovaskulyarnoy glaukomoy [Dynamics of development of iris neovascularization depending on the level of vasomotor factors in patients with neovascular glaucoma]. Archive of Ukrainian Ophthalmology. 2013;1(1):55–59. doi: 10.22141/2309-8147.1.1.2013.173772. (Ukrainian)

3. 3. Li YJ, Hu D, Lv PL et al. Expression of platelet-derived growth factor-C in aqueous humor of patients with neovascular glaucoma and its correlation with vascular endothelial growth factor. Eur J Ophthalmol. 2020;30(3):500–505. doi: 10.1177/1120672119832785.

4. 4. Sun Y, Liang Y, Zhou P et al. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term. BMC Ophthalmol. 2016;16(1):1-8. doi: 10.1186/s12886-016-0327-9.

5. 5. Junki K, Kyung R. Effect of Preoperative Intravitreal Bevacizumab on the Surgical. Outcome of Neovascular Glaucoma at Different Stages. J. Ophthalm. 2017;1:1-7. doi: 10.1155/2017/7672485.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3